NVST
Envista Holdings Corp
NYSE: NVST · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES
$23.94
+1.53% today
Updated 2026-10-28
Market cap
$3.68B
P/E ratio
39.48
P/S ratio
1.29x
EPS (TTM)
$0.58
Dividend yield
—
52W range
$19 – $30
Volume
2.7M
Envista Holdings Corp (NVST) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$23.94
12-Month target
$13.10
2030 Target
—
Intrinsic (DCF)
—
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $2.5B | $2.6B | $2.6B | $2.5B | $2.7B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 25.00x (capped 25x) · Margin: 3.33%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.